Mindfulness for Migraine & Pain Relief
You are currently watching a preview of this interview. Unlock the full version by upgrading to an Access Pass bundle! Get FREE access to 8 expert interviews from Day 1 and Day 2 when you register today!
- What are the four behavioral therapies for migraine management established by the American Headache Society guidelines?
- What is cognitive behavioral therapy (CBT)?
- What is biofeedback and what are some of the most common forms?
- What are some lifestyle modifications for migraine management?
- How can relaxation therapy be used for managing migraine attacks?
- What is mindfulness?
- What is the relationship between mindfulness and meditation in migraine management?
- How can mindfulness-based stress reduction (MBSR) be helpful for migraine management?
- What are the various approaches to mindfulness and how are they implemented?
- What are some apps for practicing mindfulness?
- Are there any risks associated with practicing mindfulness?
- Dr. Mia Minen
- Study on the use of smartphone apps for common neurologic conditions
- Study on mindfulness-based CBT and chronic and episodic migraine
- Study on the underuse of behavioral therapy for headache
- Living Well With Pain and Illness: The Mindful Way to Free Yourself From Suffering by Vidyamala Burch
- Atomic Habits by James Clear
- AHS behavioral treatment guidelines
- Jon Kabat-Zinn
- Headspace App
- Curable App
- RELAXaHead App (currently available only to research participants)
- Twitter: Dr. Mia Minen
- Electromyographic biofeedback (EMG-BFB)
- Heart rate variability biofeedback
- Lifestyle factors (sleep hygiene, hydration, nutrition, exercise, stress)
- Mindfulness-based cognitive therapy
- Mindfulness-based stress reduction (MBSR)
- Relaxation therapy
- Thermal biofeedback
Please note: The Migraine World Summit’s aim is to bring you a variety of perspectives and expertise, independent of bias or judgment. Alternative theories presented in this video have not been medically reviewed. Views expressed in this interview do not necessarily represent the views of the Migraine World Summit. Please always consult your health care professional and do your own research before making changes to your treatment plan.
Mia T. Minen, MD, MPH, FAHS
Associate Professor, Department of Neurology
NYU Grossman School of Medicine
Mia T. Minen, MD, MPH, FAHS, is a board-certified headache specialist who treats a wide variety of conditions, including migraine, tension-type headaches, cluster headaches, and postconcussive and postsurgical headaches. Treatment may include the use of medications, but Dr. Minen has a particular interest in nonpharmacologic therapies, including cognitive behavioral therapy, biofeedback, relaxation, sleep assessments, and temporomandibular joint dysfunction assessments.
Dr. Minen’s research interests revolve around improving the diagnosis and treatment of people with migraine by doctors in various medical specialties, including emergency medicine, primary care, psychiatry, and other specialty areas. She is also interested in headaches that are associated with behavioral and psychiatric problems, as well as in headache education.
Dr. Minen has published numerous research articles and lectured at annual meetings, including those of the American Academy of Neurology and the American Headache Society. She serves on the editorial board of the journal Headache.
Pre-purchase full access to the entire [YEAR] Summit, including:
- All expert interviews with separate audio (MP3) files & transcripts
- 30 extended, uncut interview editions with 6.5 hours of bonus expert footage
- Lifetime access with no annual fee
Related Talks for: Day 7 – 2023
Our ongoing mission is to make life better for the millions of Americans living with headache disorders in our country. Founded in 2008, the AHDA is a 501(c)(6) nonprofit supported by member contributions and individual donors. We are proud to have never taken direct contributions from pharmaceutical companies. Members include organizations, medical providers, scientists, caregivers, and people living with headache disorders.
At AbbVie, we are committed to empowering people living with migraine disease. We advance science that enables health care providers to care for people impacted across the spectrum of migraine. Through education and partnerships with the migraine community, we strive to help those with migraine navigate barriers to care, access effective treatments and reduce the impact of migraine on their lives. To learn more, visit AbbVie.com.